Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose steroid to reduce seroma after mastectomy: randomized pilot study
2005-004180-28Phase 2Completed
- Sponsor
- Herlev Hospital Department of Breast Surgery
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of methylprednisolone in Seroma (2 arms), sponsored by Herlev Hospital Department of Breast Surgery. Primary endpoints: Total seroma volume after drain removal and Number of seroma aspirations. Started Oct 2005; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Seroma
Beyond the preview
Go deeper on 2005-004180-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004180-28.